Search research articles
Contact Us
Filters
Showing results (51-60 of 264) with videos related to
Page
of 27
Sort By:
Clinical Genitourinary Cancer
|
October 11, 2017
Screen Failure Rates in Contemporary Randomized Clinical Phase II/III Therapeutic Trials in Genitourinary Malignancies
Sarah E Wong, Scott A North, Christopher J Sweeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 21, 2022
Reply to L. Marandino et al
Martin R Stockler, Andrew J Martin, Haryana M Dhillon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate
Noah M Hahn, Maria Reckova, Liang Cheng, et al.
Endocrine-Related Cancer
|
November 26, 2024
Association of serum steroids with survival in metastatic hormone-sensitive prostate cancer
Elahe A Mostaghel, Victoria Wang, Brett T Marck, et al.
Molecular Cancer Research : MCR
|
April 17, 2021
NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants
Katherine L Morel, Anis A Hamid, John G Clohessy, et al.
Future Oncology (London, England)
|
November 29, 2007
Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications
Noah M Hahn, Mark R Kelley, James E Klaunig, et al.
Prostate Cancer and Prostatic Diseases
|
January 8, 2025
Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer
Praful Ravi, Wanling Xie, Silke Gillessen, et al.
Clinical Genitourinary Cancer
|
May 27, 2019
Body Mass Index and Outcomes in Germ-Cell Tumors
Bradley A McGregor, Rowan E Miller, Elizabeth O'Donnell, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 23, 2023
Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment
Anis A Hamid, Nicolas Sayegh, Bertrand Tombal, et al.
The Prostate
|
March 9, 2010
A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species
Rajasubramaniam Shanmugam, Praveen Kusumanchi, Liang Cheng, et al.
Page
of 27
Search research articles
Search
Showing results (51-60 of 264) with videos related to
Sort By:
Page
of 27
Clinical Genitourinary Cancer
|
October 11, 2017
Screen Failure Rates in Contemporary Randomized Clinical Phase II/III Therapeutic Trials in Genitourinary Malignancies
Sarah E Wong, Scott A North, Christopher J Sweeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 21, 2022
Reply to L. Marandino et al
Martin R Stockler, Andrew J Martin, Haryana M Dhillon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate
Noah M Hahn, Maria Reckova, Liang Cheng, et al.
Endocrine-Related Cancer
|
November 26, 2024
Association of serum steroids with survival in metastatic hormone-sensitive prostate cancer
Elahe A Mostaghel, Victoria Wang, Brett T Marck, et al.
Molecular Cancer Research : MCR
|
April 17, 2021
NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants
Katherine L Morel, Anis A Hamid, John G Clohessy, et al.
Future Oncology (London, England)
|
November 29, 2007
Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications
Noah M Hahn, Mark R Kelley, James E Klaunig, et al.
Prostate Cancer and Prostatic Diseases
|
January 8, 2025
Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer
Praful Ravi, Wanling Xie, Silke Gillessen, et al.
Clinical Genitourinary Cancer
|
May 27, 2019
Body Mass Index and Outcomes in Germ-Cell Tumors
Bradley A McGregor, Rowan E Miller, Elizabeth O'Donnell, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 23, 2023
Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment
Anis A Hamid, Nicolas Sayegh, Bertrand Tombal, et al.
The Prostate
|
March 9, 2010
A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species
Rajasubramaniam Shanmugam, Praveen Kusumanchi, Liang Cheng, et al.
Page
of 27